PONZ DE LEON, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 41.025
AS - Asia 18.016
EU - Europa 16.118
SA - Sud America 2.521
AF - Africa 323
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 18
Totale 78.049
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 40.588
GB - Regno Unito 7.278
SG - Singapore 6.130
CN - Cina 5.072
HK - Hong Kong 2.055
BR - Brasile 1.964
VN - Vietnam 1.672
SE - Svezia 1.553
DE - Germania 1.435
IT - Italia 1.393
UA - Ucraina 1.093
FI - Finlandia 981
TR - Turchia 875
RU - Federazione Russa 663
FR - Francia 620
KR - Corea 493
BG - Bulgaria 388
BD - Bangladesh 346
IN - India 346
CA - Canada 210
AR - Argentina 202
ID - Indonesia 150
IQ - Iraq 143
MX - Messico 142
NL - Olanda 122
JP - Giappone 114
EC - Ecuador 99
ZA - Sudafrica 97
IE - Irlanda 86
BE - Belgio 83
PK - Pakistan 83
ES - Italia 78
AE - Emirati Arabi Uniti 71
CO - Colombia 65
PL - Polonia 63
CL - Cile 58
VE - Venezuela 58
MY - Malesia 48
UZ - Uzbekistan 45
SA - Arabia Saudita 43
AT - Austria 41
MA - Marocco 39
PH - Filippine 38
NP - Nepal 36
LT - Lituania 33
RO - Romania 33
TN - Tunisia 33
EG - Egitto 32
KE - Kenya 30
DZ - Algeria 29
JO - Giordania 28
TH - Thailandia 28
AZ - Azerbaigian 27
CZ - Repubblica Ceca 26
PY - Paraguay 26
TW - Taiwan 23
AU - Australia 21
IL - Israele 20
PE - Perù 20
OM - Oman 16
CH - Svizzera 15
IR - Iran 15
KZ - Kazakistan 15
PT - Portogallo 14
DO - Repubblica Dominicana 13
JM - Giamaica 13
AL - Albania 12
BO - Bolivia 12
BY - Bielorussia 12
CR - Costa Rica 12
DK - Danimarca 12
UY - Uruguay 12
ET - Etiopia 11
EU - Europa 11
SY - Repubblica araba siriana 11
GE - Georgia 10
GR - Grecia 9
LB - Libano 9
MD - Moldavia 9
PS - Palestinian Territory 9
RS - Serbia 9
PA - Panama 8
HR - Croazia 7
KG - Kirghizistan 7
KW - Kuwait 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
PR - Porto Rico 7
SN - Senegal 7
BA - Bosnia-Erzegovina 6
HU - Ungheria 6
LK - Sri Lanka 6
NG - Nigeria 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BH - Bahrain 5
BZ - Belize 5
EE - Estonia 5
GA - Gabon 5
HN - Honduras 5
MK - Macedonia 5
Totale 77.945
Salva come PNG Salva come JPEG
Città #
Southend 5.521
Singapore 4.103
Fairfield 3.408
Santa Clara 3.230
Ashburn 3.206
Woodbridge 2.650
Jacksonville 2.221
Houston 2.212
Hong Kong 2.035
Chandler 1.835
Hefei 1.744
Dearborn 1.426
Ann Arbor 1.336
Wilmington 1.315
Seattle 1.289
Chicago 1.271
Cambridge 1.116
San Jose 1.077
Los Angeles 919
Beijing 911
Nyköping 895
London 861
Helsinki 579
The Dalles 544
Salt Lake City 543
Ho Chi Minh City 513
Princeton 486
Izmir 463
Seoul 451
Hanoi 406
Sofia 380
Eugene 367
Modena 366
San Diego 358
New York 317
Council Bluffs 311
Lauterbourg 299
Des Moines 289
Elk Grove Village 253
Tampa 239
Buffalo 237
Dallas 227
Moscow 224
Shanghai 191
Milan 174
São Paulo 158
Columbus 140
Sterling 138
Frankfurt am Main 136
Lancaster 125
Bremen 114
Munich 113
Grafing 101
Miami 101
Falls Church 99
Orem 92
Tokyo 92
Phoenix 91
Da Nang 88
Jakarta 79
Atlanta 73
Boardman 72
Guangzhou 72
Dulles 66
Detroit 65
Brussels 62
Haiphong 62
Rio de Janeiro 62
Dublin 61
Norwalk 61
Falkenstein 58
Mexico City 58
Fremont 57
Baghdad 56
Kunming 56
Chennai 55
Nanjing 54
Belo Horizonte 50
Brooklyn 48
Kent 47
Rochester 47
Montreal 46
Quito 46
Toronto 46
Kansas City 45
Denver 43
Cardiff 42
Philadelphia 41
Dhaka 40
Pittsburgh 40
Tashkent 40
Turku 40
Jinan 38
Miano 37
Rome 37
Curitiba 36
Nuremberg 36
Porto Alegre 36
Brasília 35
San Francisco 35
Totale 56.466
Salva come PNG Salva come JPEG
Nome #
Estimates of cancer burden in Italy 699
Surgical management of the duodenal manifestations of familial adenomatous polyposis 534
EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century 466
Attitude of the Italian general population towards prevention and screening of the most common tumors, with special emphasis on colorectal malignancies. 451
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 450
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 441
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 436
Differentiated Thyroid Carcinoma (DTC) in a Young Woman with Peutz-Jeghers Syndrome: are these Two Conditions Associated? 432
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 422
Attenuated polyposis of the large bowel: a morphologic and molecular approach 418
Lymph node micrometastasis and survival of patients with Stage i (Dukes' A) colorectal carcinoma 417
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 407
A two-locus model for hereditary non-polyposis colorectal cancer in Modena, Italy 406
Long-term survey of patients with curable colorectal cancer with specific reference to the quality of life. 399
Survival, surgical management and perioperative mortality of colorectal cancer in the 21-year experience of a specialised registry 399
Morphological and quantitative analysis of BCL6 expression in human colorectal carcinogenesis. 397
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1 alpha protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis 395
K-ras and p53 mutations in human colorectal aberrant crypt foci 390
Pattern of cell kinetics in colorectal mucosa of patients with different types of adenomatous polyps of the large bowel 388
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 387
Microsatellite instability in multiple colorectal tumors 381
A genetic model for determining MSH2 and MLH1 carrier probabilities based on family history and tumor microsatellite instability. 380
An unusual case of familial adenomatous polyposis with very early symptom occurrence 379
The influence of age on colonic epithelial cell proliferation 371
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 371
Aetiology of colorectal cancer and relevance of monogenic inheritance. 369
IDENTIFICATION OF HEREDITARY NONPOLYPOSIS COLORECTAL-CANCER IN THE GENERAL-POPULATION - THE 6-YEAR EXPERIENCE OF A POPULATION-BASED REGISTRY 368
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 368
The cause of colorectal cancer 363
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome 363
Aberrant crypt foci in patients with colorectal cancer 361
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 360
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 358
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 358
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 356
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 352
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 345
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 343
Matrix metalloproteinases 15 and 19 are stromal regulators of colorectal cancer development from the early stages 340
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 339
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 338
Survival analysis in families affected by hereditary non-polyposis colorectal cancer 333
Histology of aberrant crypt foci in the human colon 332
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 330
Clinical features and colorectal cancer survival: an attempt to explain differences between two different Italian regions. 326
Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study 326
PLZF expression during colorectal cancer development and in normal colorectal mucosa according to body size, as marker of colorectal cancer risk. 322
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 321
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 320
First observation of microadenomas in the ileal mucosa of patients with familial adenomatous polyposis and colectomies 319
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 319
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 318
Carcinoma papillare e Sindrome di Peutz-Jeghers: una rara associazione 317
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 316
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 315
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 311
Clinical features of colorectal cancer patients in advanced age: a population-based approach 307
Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects 304
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 303
Cholesterol esterase activity of human intestinal mucosa 299
Effect of the selective expansion of cholic acid pool on bile lipid composition: possible mechanism of bile acid induced biliary cholesterol desaturation. 299
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 299
Microsatellite instability and colorectal cancer prognosis. 296
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 294
EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary 293
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 293
Stage I colorectal carcinoma: VEGF immunohistochemical expression, microvessel density, and their correlation with clinical outcome. 292
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 291
Cancer prevalence in Italian cancer registry areas: The ITAPREVAL study 290
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 289
Familial aggregation of tumors and detection of hereditary non-polyposis colorectal cancer in 3-year experience of 2 population-based colorectal-cancer registries 287
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 286
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 284
Infliximab-related hepatitis: discussion of a case and review of the literature. 283
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 283
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 280
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 278
Alteration of drug metabolism during cholestasis in man 277
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 274
Colorectal carcinoma in different age groups: A population based investigation 272
Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid. 272
The perception of health-related quality of life in colon cancer patients during chemotherapy: differences between men and women 271
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis 268
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 267
Effects of acute changes of bile acid pool composition on biliary lipid secretion 266
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 266
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 266
Disease presentation, treatment and survival for Italian colorectal cancer patients: a EUROCARE high resolution study 266
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 265
Peutz-Jeghers syndrome: a systematic review and recommendations for management 265
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 265
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: A retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database 265
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 264
Antioxidant vitamins and colorectal adenoma 263
In response. Adjuvant chemotherapy in colorectal cancer patients with microsatellite instability. 261
Colorectal carcinoma grading by quantifying poorly differentiated cell clusters is more reproducible and provides more robust prognostic information than conventional grading. 261
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 260
Biological characterization of mucinous carcinoma of the colon and rectum 258
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 257
Preventive war and chemoprevention of cancer 257
Totale 33.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 303.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 303.926
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021634 0 0 0 0 0 0 0 0 0 0 352 282
2021/20225.836 154 907 466 488 134 285 358 273 633 392 1.072 674
2022/20235.088 686 528 321 499 628 951 66 451 608 35 189 126
2023/20243.078 120 211 186 190 799 257 298 435 81 47 98 356
2024/202511.798 445 117 146 870 2.404 1.693 767 654 1.310 708 1.238 1.446
2025/202625.403 1.449 1.011 2.235 3.595 5.892 1.675 2.785 1.323 2.027 1.827 1.584 0
Totale 78.315